Share capital increase by issue of new ordinary shares of the Company by an amount of up to EUR 200 million (including issue premium) within the authorised capital with disapplication of the statutory preferential subscription rights of existing shareholders and application of Preferential Allocation to Existing Minority Shareholders of the Company, subject to approval of the prospectus that the Company intends to issue in respect of the transaction.